|
Asymchem Laboratories Co., Ltd. (6821.hk) Valation DCF
CN | Healthcare | Biotechnology | HKSE
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) Bundle
Découvrez le véritable potentiel d'Asymchem Laboratories (Tianjin) Co., Ltd. (6821HK) avec notre calculatrice DCF au niveau expert! Ajustez les hypothèses clés, explorez divers scénarios et évaluez comment les différents changements affectent l'évaluation des laboratoires Asymchem (Tianjin) Co., Ltd. (6821HK) - le tout dans un modèle Excel pratique.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,635.5 | 3,374.4 | 4,969.8 | 10,987.1 | 8,383.5 | 11,561.3 | 15,943.6 | 21,987.0 | 30,321.2 | 41,814.4 |
| Revenue Growth, % | 0 | 28.04 | 47.28 | 121.08 | -23.7 | 37.9 | 37.9 | 37.9 | 37.9 | 37.9 |
| EBITDA | 799.9 | 1,043.2 | 1,515.5 | 4,368.1 | 3,243.0 | 3,935.4 | 5,427.1 | 7,484.3 | 10,321.2 | 14,233.4 |
| EBITDA, % | 30.35 | 30.91 | 30.49 | 39.76 | 38.68 | 34.04 | 34.04 | 34.04 | 34.04 | 34.04 |
| Depreciation | 131.0 | 168.0 | 229.6 | 366.1 | 497.0 | 551.0 | 759.9 | 1,047.9 | 1,445.1 | 1,992.8 |
| Depreciation, % | 4.97 | 4.98 | 4.62 | 3.33 | 5.93 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 |
| EBIT | 668.9 | 875.1 | 1,285.9 | 4,002.0 | 2,745.9 | 3,384.4 | 4,667.3 | 6,436.4 | 8,876.1 | 12,240.6 |
| EBIT, % | 25.38 | 25.93 | 25.87 | 36.42 | 32.75 | 29.27 | 29.27 | 29.27 | 29.27 | 29.27 |
| Total Cash | 466.3 | 2,276.2 | 7,109.1 | 7,971.6 | 9,659.1 | 8,271.0 | 11,406.1 | 15,729.6 | 21,691.9 | 29,914.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 705.5 | 1,057.6 | 1,279.0 | 2,821.6 | .0 | 2,532.6 | 3,492.5 | 4,816.4 | 6,642.0 | 9,159.6 |
| Account Receivables, % | 26.77 | 31.34 | 25.73 | 25.68 | 0.0000000383 | 21.91 | 21.91 | 21.91 | 21.91 | 21.91 |
| Inventories | 480.8 | 778.2 | 1,495.7 | 1,618.2 | 1,012.8 | 2,270.9 | 3,131.7 | 4,318.7 | 5,955.7 | 8,213.2 |
| Inventories, % | 18.24 | 23.06 | 30.1 | 14.73 | 12.08 | 19.64 | 19.64 | 19.64 | 19.64 | 19.64 |
| Accounts Payable | 286.0 | 405.6 | 591.2 | 609.5 | 486.0 | 1,066.3 | 1,470.5 | 2,027.8 | 2,796.5 | 3,856.5 |
| Accounts Payable, % | 10.85 | 12.02 | 11.9 | 5.55 | 5.8 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 |
| Capital Expenditure | -547.2 | -1,087.4 | -1,778.2 | -2,304.1 | -1,330.2 | -2,904.3 | -4,005.1 | -5,523.3 | -7,616.9 | -10,504.1 |
| Capital Expenditure, % | -20.76 | -32.22 | -35.78 | -20.97 | -15.87 | -25.12 | -25.12 | -25.12 | -25.12 | -25.12 |
| Tax Rate, % | 11.28 | 11.28 | 11.28 | 11.28 | 11.28 | 11.28 | 11.28 | 11.28 | 11.28 | 11.28 |
| EBITAT | 594.1 | 776.0 | 1,152.6 | 3,547.2 | 2,436.3 | 3,008.6 | 4,149.0 | 5,721.7 | 7,890.6 | 10,881.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -722.4 | -673.3 | -1,149.2 | -37.6 | 4,906.6 | -2,555.0 | -512.8 | -707.2 | -975.3 | -1,344.9 |
| WACC, % | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5,325.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1,372 | |||||||||
| Terminal Value | -41,460 | |||||||||
| Present Terminal Value | -32,012 | |||||||||
| Enterprise Value | -37,337 | |||||||||
| Net Debt | -7,490 | |||||||||
| Equity Value | -29,847 | |||||||||
| Diluted Shares Outstanding, MM | 362 | |||||||||
| Equity Value Per Share | -82.35 |
What You Will Receive
- Customizable Excel Template: An entirely adaptable Excel-based DCF Calculator featuring pre-filled financial data for Asymchem Laboratories (Tianjin) Co., Ltd. (6821HK).
- Accurate Data: Historical performance metrics and projected estimates (displayed in the highlighted cells).
- Flexible Forecasting: Adjust forecast parameters like revenue growth, EBITDA %, and WACC as needed.
- Instant Calculations: Quickly observe how your inputs influence the valuation of Asymchem Laboratories (Tianjin) Co., Ltd. (6821HK).
- Professional-Grade Tool: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Created for clarity and user-friendliness, complemented by step-by-step guidance.
Key Features
- 🔍 Real-Life (6821HK) Financials: Pre-filled historical and projected data for Asymchem Laboratories (Tianjin) Co., Ltd.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas compute Asymchem's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Asymchem's valuation immediately after making adjustments.
- Scenario Analysis: Test and compare outcomes for different financial assumptions side-by-side.
How It Functions
- Download: Obtain the pre-prepared Excel file containing Asymchem Laboratories' financial data.
- Customize: Tailor your projections, adjusting parameters such as revenue growth, EBITDA percentage, and WACC.
- Real-Time Updates: The intrinsic value and NPV calculations refresh automatically as you make changes.
- Scenario Testing: Generate various forecasts and evaluate results instantly.
- Strategic Decisions: Leverage the valuation insights to inform your investment approach.
Why Choose This Calculator for Asymchem Laboratories (6821HK)?
- User-Friendly Design: Perfect for both novices and seasoned professionals.
- Customizable Parameters: Adjust inputs effortlessly to tailor your analysis.
- Real-Time Adjustments: Observe immediate updates to Asymchem's valuation as you modify inputs.
- Preloaded Data: Includes Asymchem’s actual financial information for swift evaluation.
- Endorsed by Experts: Utilized by investors and analysts for well-informed decision-making.
Who Can Benefit from This Product?
- Investors: Accurately assess Asymchem's (6821HK) fair value to inform your investment choices.
- CFOs: Utilize a high-quality DCF model for precise financial reporting and analysis.
- Consultants: Quickly customize the template for client valuation reports.
- Entrepreneurs: Gain valuable insights into financial modeling practices employed by leading firms.
- Educators: Employ this resource as a teaching aid to illustrate valuation techniques.
Contents of the Template
- Pre-Filled DCF Model: Asymchem's financial data preloaded for immediate application.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Asymchem's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth rates, profit margins, and capital expenditures to suit your scenarios.
- Financial Statements: Access annual and quarterly reports for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.